Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica

Abstract

Plasmapheresis is a safe and efficient add-on therapy in NMO, especially in steroid-resistant cases. Although the volumes of plasma treated during acute plasmapheresis were less than recommended minimum volumes, majority of patients had significant clinical improvement.